PureTech Health plc (LON:PRTC – Get Free Report) shares crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 155.86 ($2.04) and traded as high as GBX 156 ($2.04). PureTech Health shares last traded at GBX 153 ($2.00), with a volume of 495,999 shares traded.
PureTech Health Stock Performance
The firm’s 50 day simple moving average is GBX 155.27 and its 200 day simple moving average is GBX 187.44. The firm has a market capitalization of £360.57 million, a price-to-earnings ratio of -654.78 and a beta of 1.02. The company has a debt-to-equity ratio of 47.27, a quick ratio of 2.51 and a current ratio of 3.68.
About PureTech Health
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Recommended Stories
- Five stocks we like better than PureTech Health
- How to Find Undervalued Stocks
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Options Trading – Understanding Strike Price
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- Using the MarketBeat Dividend Yield Calculator
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
